Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Fas expression and function in normal and malignant breast cell lines

M M Keane1, S A Ettenberg, G A Lowrey

  • 1National Cancer Institute, Navy Medical Oncology Branch, National Naval Medical Center, Bethesda, Maryland 20889-5105, USA.

Cancer Research
|October 15, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Predicting neoadjuvant breast cancer therapy response using BRIDGE from tumor transcriptomics and histopathology.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

First-in-human phase 0 study of <sup>111</sup>In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging.

Journal of translational science·2019
Same author

Medial Temporal Lobe Contributions to Episodic Future Thinking: Scene Construction or Future Projection?

Cerebral cortex (New York, N.Y. : 1991)·2016
Same author

Using future thinking to reduce temporal discounting: Under what circumstances are the medial temporal lobes critical?

Neuropsychologia·2016
Same author

Characterization of activating mutations of NOTCH3 in T-cell acute lymphoblastic leukemia and anti-leukemic activity of NOTCH3 inhibitory antibodies.

Oncogene·2016
Same author

Does the hippocampus keep track of time?

Hippocampus·2015

Breast cancer cells often resist apoptosis due to low Fas pathway expression. Interferon-gamma can restore sensitivity by upregulating key enzymes like ICE, offering a potential therapeutic strategy.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • The Fas apoptotic pathway plays a critical role in programmed cell death.
  • Dysregulation of the Fas pathway is implicated in various cancers, including breast cancer.
  • Understanding Fas pathway function in breast cancer is crucial for developing targeted therapies.

Purpose of the Study:

  • To investigate the expression and function of the Fas apoptotic pathway in normal and malignant human breast epithelial cells.
  • To determine the role of Interferon-gamma (IFN-gamma) in modulating Fas-mediated apoptosis in breast cancer cells.
  • To elucidate the involvement of Interleukin-1beta-converting enzyme (ICE) in Fas-mediated apoptosis.

Main Methods:

  • Analysis of Fas mRNA and protein expression in breast epithelial cell lines.

Related Experiment Videos

  • Induction of apoptosis using anti-Fas antibodies.
  • Treatment of cell lines with IFN-gamma to assess changes in Fas sensitivity.
  • Assessment of ICE expression and inhibition studies using YVAD-cmk.
  • Gene transfection to restore ICE expression.

    • Main Results:

    • Normal breast cells express high Fas levels and undergo apoptosis, while most breast cancer cells are resistant.
    • IFN-gamma treatment restored Fas-mediated apoptosis in four of five resistant breast cancer cell lines.
    • Increased ICE expression correlated with restored Fas sensitivity, and ICE inhibition blocked apoptosis.
    • Transfection of ICE reconstituted Fas sensitivity in resistant cells.

    Conclusions:

    • Down-regulation of the Fas pathway may be a mechanism in breast cancer progression.
    • IFN-gamma can re-sensitize breast cancer cells to Fas-mediated apoptosis, partly through increased ICE expression.
    • Modulating Fas pathway components, particularly ICE, presents a potential therapeutic strategy for breast cancer treatment.